0.54
CRISPR Therapeutics AG
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
−0.50
FY23:
−0.26
FY24:
−0.14
FY25:
−0.35
Change from FY21 to FY25
billions USD
FY21:
−1.04
FY22:
−0.26
FY23:
0.37
FY24:
−0.28
FY25:
−0.03
Change from FY21 to FY25
billions USD
FY21:
0.25
FY22:
0.04
FY23:
0.06
FY24:
0.33
FY25:
0.43
billions USD
FY21:
−0.25
FY22:
−0.72
FY23:
0.18
FY24:
−0.09
FY25:
0.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.46
FY22:
−0.53
FY23:
−0.27
FY24:
−0.14
FY25:
−0.35
All amounts in billions USD